These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3297120)

  • 21. Beta receptor blocking agents in the secondary prevention of coronary heart disease.
    Vedin JA; Wilhelmsson CE
    Annu Rev Pharmacol Toxicol; 1983; 23():29-44. PubMed ID: 6135389
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of long-term oral anticoagulant treatment on mortality and cardiovascular morbidity after myocardial infarction. Anticoagulants in the Secondary Prevention of Events in Coronary Thrombosis (ASPECT) Research Group.
    Lancet; 1994 Feb; 343(8896):499-503. PubMed ID: 7906757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term anticoagulant therapy after acute myocardial infarction.
    Goldberg RJ; Gore JM; Dalen JE; Alpert JS
    Am Heart J; 1985 Mar; 109(3 Pt 1):616-22. PubMed ID: 3919548
    [No Abstract]   [Full Text] [Related]  

  • 24. Relevance of clinical trial results in myocardial infarction to medical practice: comparison of four year outcome in participants of a thrombolytic trial, patients receiving routine thrombolysis, and those deemed ineligible for thrombolysis.
    Brown N; Melville M; Gray D; Young T; Skene AM; Wilcox RG; Hampton JR
    Heart; 1999 Jun; 81(6):598-602. PubMed ID: 10336917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduction in sudden deaths by a multifactorial intervention programme after acute myocardial infarction.
    Kallio V; Hämäläinen H; Hakkila J; Luurila OJ
    Lancet; 1979 Nov; 2(8152):1091-4. PubMed ID: 91836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myocardial infarction mortality risk after treatment for Hodgkin disease: a collaborative British cohort study.
    Swerdlow AJ; Higgins CD; Smith P; Cunningham D; Hancock BW; Horwich A; Hoskin PJ; Lister A; Radford JA; Rohatiner AZ; Linch DC
    J Natl Cancer Inst; 2007 Feb; 99(3):206-14. PubMed ID: 17284715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term anticoagulant prophylaxis after myocardial infarction.
    Seaman AJ; Griswold HE; Reaume RB; Ritzmann L
    N Engl J Med; 1969 Jul; 281(3):115-9. PubMed ID: 4307139
    [No Abstract]   [Full Text] [Related]  

  • 28. A multicenter study on timolol in secondary prevention after myocardial infarction.
    Acta Med Scand Suppl; 1983; 674():1-129. PubMed ID: 6580807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of long-term anticoagulant treatment in subgroups of patients after myocardial infarction.
    van Bergen PF; Deckers JW; Jonker JJ; van Domburg RT; Azar AJ; Hofman A
    Br Heart J; 1995 Aug; 74(2):117-21. PubMed ID: 7546987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early invasive versus non-invasive treatment in patients with non-ST-elevation acute coronary syndrome (FRISC-II): 15 year follow-up of a prospective, randomised, multicentre study.
    Wallentin L; Lindhagen L; Ärnström E; Husted S; Janzon M; Johnsen SP; Kontny F; Kempf T; Levin LÅ; Lindahl B; Stridsberg M; Ståhle E; Venge P; Wollert KC; Swahn E; Lagerqvist B;
    Lancet; 2016 Oct; 388(10054):1903-1911. PubMed ID: 27585757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The German-Austrian aspirin trial: a comparison of acetylsalicylic acid, placebo and phenprocoumon in secondary prevention of myocardial infarction. On behalf of the German-Austrian Study Group.
    Breddin K; Loew D; Lechner K; Oberla K; Walter E
    Circulation; 1980 Dec; 62(6 Pt 2):V63-72. PubMed ID: 6777073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sulfinpyrazone in the prevention of sudden death after myocardial infarction.
    Anturane Reinfarction Trial Research Group
    N Engl J Med; 1980 Jan; 302(5):250-6. PubMed ID: 6985706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent trends in acute coronary heart disease--mortality, morbidity, medical care, and risk factors. The Minnesota Heart Survey Investigators.
    McGovern PG; Pankow JS; Shahar E; Doliszny KM; Folsom AR; Blackburn H; Luepker RV
    N Engl J Med; 1996 Apr; 334(14):884-90. PubMed ID: 8596571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomised multicentre trial of early mobilisation after uncomplicated myocardial infarction.
    West RR; Henderson AH
    Br Heart J; 1979 Oct; 42(4):381-5. PubMed ID: 389259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors influenceing long-term prognosis in male patients surviving a first coronary attack.
    Mulcahy R; Hickey N; Graham I; McKenzie G
    Br Heart J; 1975 Feb; 37(2):158-65. PubMed ID: 1122271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Remote ischemic preconditioning improves outcome at 6 years after elective percutaneous coronary intervention: the CRISP stent trial long-term follow-up.
    Davies WR; Brown AJ; Watson W; McCormick LM; West NE; Dutka DP; Hoole SP
    Circ Cardiovasc Interv; 2013 Jun; 6(3):246-51. PubMed ID: 23696599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term mortality and hospital readmission after acute myocardial infarction: an eight-year follow-up study.
    Andrés E; Cordero A; Magán P; Alegría E; León M; Luengo E; Botaya RM; García Ortiz L; Casasnovas JA
    Rev Esp Cardiol (Engl Ed); 2012 May; 65(5):414-20. PubMed ID: 22133784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prevention of a second myocardial infarct by way of prolonged use of anticoagulants with indirect action].
    Bykov II
    Kardiologiia; 1968 Sep; 8(9):76-8. PubMed ID: 5728509
    [No Abstract]   [Full Text] [Related]  

  • 39. [Angiotensin-converting enzyme inhibitors in patients with preserved left ventricular function: from EUROPA to PREAMI].
    Ferrari R; Papa K; Bernocchi P; Gimbatti OJ; Golcea SS; Bettini A; Ceconi C
    Ital Heart J; 2005 Nov; 6 Suppl 7():24S-32S. PubMed ID: 16485514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994.
    Rosamond WD; Chambless LE; Folsom AR; Cooper LS; Conwill DE; Clegg L; Wang CH; Heiss G
    N Engl J Med; 1998 Sep; 339(13):861-7. PubMed ID: 9744969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.